19-35904661-A-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_003332.4(TYROBP):​c.277-27T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00406 in 1,606,250 control chromosomes in the GnomAD database, including 101 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.012 ( 22 hom., cov: 31)
Exomes 𝑓: 0.0032 ( 79 hom. )

Consequence

TYROBP
NM_003332.4 intron

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.0420

Publications

2 publications found
Variant links:
Genes affected
TYROBP (HGNC:12449): (transmembrane immune signaling adaptor TYROBP) This gene encodes a transmembrane signaling polypeptide which contains an immunoreceptor tyrosine-based activation motif (ITAM) in its cytoplasmic domain. The encoded protein may associate with the killer-cell inhibitory receptor (KIR) family of membrane glycoproteins and may act as an activating signal transduction element. This protein may bind zeta-chain (TCR) associated protein kinase 70kDa (ZAP-70) and spleen tyrosine kinase (SYK) and play a role in signal transduction, bone modeling, brain myelination, and inflammation. Mutations within this gene have been associated with polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL), also known as Nasu-Hakola disease. Its putative receptor, triggering receptor expressed on myeloid cells 2 (TREM2), also causes PLOSL. Multiple alternative transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Mar 2010]
TYROBP Gene-Disease associations (from GenCC):
  • polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • polycystic lipomembranous osteodysplasia with sclerosing leukoencephaly
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 19-35904661-A-C is Benign according to our data. Variant chr19-35904661-A-C is described in ClinVar as Likely_benign. ClinVar VariationId is 1220182.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0119 (1809/152244) while in subpopulation AFR AF = 0.034 (1412/41528). AF 95% confidence interval is 0.0325. There are 22 homozygotes in GnomAd4. There are 863 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 22 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003332.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TYROBP
NM_003332.4
MANE Select
c.277-27T>G
intron
N/ANP_003323.1O43914-1
TYROBP
NM_198125.3
c.274-27T>G
intron
N/ANP_937758.1O43914-2
TYROBP
NM_001173514.2
c.244-27T>G
intron
N/ANP_001166985.1O43914-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TYROBP
ENST00000262629.9
TSL:1 MANE Select
c.277-27T>G
intron
N/AENSP00000262629.3O43914-1
TYROBP
ENST00000589517.1
TSL:1
c.274-27T>G
intron
N/AENSP00000468447.1O43914-2
TYROBP
ENST00000544690.6
TSL:1
c.244-27T>G
intron
N/AENSP00000445332.1O43914-3

Frequencies

GnomAD3 genomes
AF:
0.0119
AC:
1805
AN:
152126
Hom.:
22
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0340
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00550
Gnomad ASJ
AF:
0.0124
Gnomad EAS
AF:
0.0325
Gnomad SAS
AF:
0.00745
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.000647
Gnomad OTH
AF:
0.00670
GnomAD2 exomes
AF:
0.00713
AC:
1699
AN:
238404
AF XY:
0.00641
show subpopulations
Gnomad AFR exome
AF:
0.0334
Gnomad AMR exome
AF:
0.00290
Gnomad ASJ exome
AF:
0.0143
Gnomad EAS exome
AF:
0.0357
Gnomad FIN exome
AF:
0.000144
Gnomad NFE exome
AF:
0.000947
Gnomad OTH exome
AF:
0.00774
GnomAD4 exome
AF:
0.00324
AC:
4708
AN:
1454006
Hom.:
79
Cov.:
30
AF XY:
0.00316
AC XY:
2284
AN XY:
722840
show subpopulations
African (AFR)
AF:
0.0334
AC:
1116
AN:
33396
American (AMR)
AF:
0.00349
AC:
153
AN:
43832
Ashkenazi Jewish (ASJ)
AF:
0.0130
AC:
336
AN:
25908
East Asian (EAS)
AF:
0.0417
AC:
1651
AN:
39622
South Asian (SAS)
AF:
0.00560
AC:
477
AN:
85168
European-Finnish (FIN)
AF:
0.000132
AC:
7
AN:
52936
Middle Eastern (MID)
AF:
0.00511
AC:
29
AN:
5672
European-Non Finnish (NFE)
AF:
0.000547
AC:
606
AN:
1107370
Other (OTH)
AF:
0.00554
AC:
333
AN:
60102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
241
483
724
966
1207
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0119
AC:
1809
AN:
152244
Hom.:
22
Cov.:
31
AF XY:
0.0116
AC XY:
863
AN XY:
74448
show subpopulations
African (AFR)
AF:
0.0340
AC:
1412
AN:
41528
American (AMR)
AF:
0.00549
AC:
84
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0124
AC:
43
AN:
3470
East Asian (EAS)
AF:
0.0326
AC:
169
AN:
5184
South Asian (SAS)
AF:
0.00746
AC:
36
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.000647
AC:
44
AN:
68008
Other (OTH)
AF:
0.00664
AC:
14
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
92
184
276
368
460
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00808
Hom.:
3
Bravo
AF:
0.0138
Asia WGS
AF:
0.0150
AC:
53
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
8.2
DANN
Benign
0.80
PhyloP100
-0.042
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs75330483; hg19: chr19-36395563; COSMIC: COSV52888420; COSMIC: COSV52888420; API